Cargando…

NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport

BACKGROUND: Bioenergetic maladaptations and axonopathy are often found in the early stages of neurodegeneration. Nicotinamide adenine dinucleotide (NAD), an essential cofactor for energy metabolism, is mainly synthesized by Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) in CNS neurons....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sen, Niou, Zhen-Xian, Enriquez, Andrea, LaMar, Jacob, Huang, Jui-Yen, Ling, Karen, Jafar-Nejad, Paymaan, Gilley, Jonathan, Coleman, Michael P., Tennessen, Jason M., Rangaraju, Vidhya, Lu, Hui-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246254/
https://www.ncbi.nlm.nih.gov/pubmed/37292715
http://dx.doi.org/10.21203/rs.3.rs-2859584/v1
_version_ 1785054996913455104
author Yang, Sen
Niou, Zhen-Xian
Enriquez, Andrea
LaMar, Jacob
Huang, Jui-Yen
Ling, Karen
Jafar-Nejad, Paymaan
Gilley, Jonathan
Coleman, Michael P.
Tennessen, Jason M.
Rangaraju, Vidhya
Lu, Hui-Chen
author_facet Yang, Sen
Niou, Zhen-Xian
Enriquez, Andrea
LaMar, Jacob
Huang, Jui-Yen
Ling, Karen
Jafar-Nejad, Paymaan
Gilley, Jonathan
Coleman, Michael P.
Tennessen, Jason M.
Rangaraju, Vidhya
Lu, Hui-Chen
author_sort Yang, Sen
collection PubMed
description BACKGROUND: Bioenergetic maladaptations and axonopathy are often found in the early stages of neurodegeneration. Nicotinamide adenine dinucleotide (NAD), an essential cofactor for energy metabolism, is mainly synthesized by Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) in CNS neurons. NMNAT2 mRNA levels are reduced in the brains of Alzheimer’s, Parkinson’s, and Huntington’s disease. Here we addressed whether NMNAT2 is required for axonal health of cortical glutamatergic neurons, whose long-projecting axons are often vulnerable in neurodegenerative conditions. We also tested if NMNAT2 maintains axonal health by ensuring axonal ATP levels for axonal transport, critical for axonal function. METHODS: We generated mouse and cultured neuron models to determine the impact of NMNAT2 loss from cortical glutamatergic neurons on axonal transport, energetic metabolism, and morphological integrity. In addition, we determined if exogenous NAD supplementation or inhibiting a NAD hydrolase, sterile alpha and TIR motif-containing protein 1 (SARM1), prevented axonal deficits caused by NMNAT2 loss. This study used a combination of genetics, molecular biology, immunohistochemistry, biochemistry, fluorescent time-lapse imaging, live imaging with optical sensors, and anti-sense oligos. RESULTS: We provide in vivo evidence that NMNAT2 in glutamatergic neurons is required for axonal survival. Using in vivo and in vitro studies, we demonstrate that NMNAT2 maintains the NAD-redox potential to provide “on-board” ATP via glycolysis to vesicular cargos in distal axons. Exogenous NAD(+) supplementation to NMNAT2 KO neurons restores glycolysis and resumes fast axonal transport. Finally, we demonstrate both in vitro and in vivo that reducing the activity of SARM1, an NAD degradation enzyme, can reduce axonal transport deficits and suppress axon degeneration in NMNAT2 KO neurons. CONCLUSION: NMNAT2 ensures axonal health by maintaining NAD redox potential in distal axons to ensure efficient vesicular glycolysis required for fast axonal transport.
format Online
Article
Text
id pubmed-10246254
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-102462542023-06-08 NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport Yang, Sen Niou, Zhen-Xian Enriquez, Andrea LaMar, Jacob Huang, Jui-Yen Ling, Karen Jafar-Nejad, Paymaan Gilley, Jonathan Coleman, Michael P. Tennessen, Jason M. Rangaraju, Vidhya Lu, Hui-Chen Res Sq Article BACKGROUND: Bioenergetic maladaptations and axonopathy are often found in the early stages of neurodegeneration. Nicotinamide adenine dinucleotide (NAD), an essential cofactor for energy metabolism, is mainly synthesized by Nicotinamide mononucleotide adenylyl transferase 2 (NMNAT2) in CNS neurons. NMNAT2 mRNA levels are reduced in the brains of Alzheimer’s, Parkinson’s, and Huntington’s disease. Here we addressed whether NMNAT2 is required for axonal health of cortical glutamatergic neurons, whose long-projecting axons are often vulnerable in neurodegenerative conditions. We also tested if NMNAT2 maintains axonal health by ensuring axonal ATP levels for axonal transport, critical for axonal function. METHODS: We generated mouse and cultured neuron models to determine the impact of NMNAT2 loss from cortical glutamatergic neurons on axonal transport, energetic metabolism, and morphological integrity. In addition, we determined if exogenous NAD supplementation or inhibiting a NAD hydrolase, sterile alpha and TIR motif-containing protein 1 (SARM1), prevented axonal deficits caused by NMNAT2 loss. This study used a combination of genetics, molecular biology, immunohistochemistry, biochemistry, fluorescent time-lapse imaging, live imaging with optical sensors, and anti-sense oligos. RESULTS: We provide in vivo evidence that NMNAT2 in glutamatergic neurons is required for axonal survival. Using in vivo and in vitro studies, we demonstrate that NMNAT2 maintains the NAD-redox potential to provide “on-board” ATP via glycolysis to vesicular cargos in distal axons. Exogenous NAD(+) supplementation to NMNAT2 KO neurons restores glycolysis and resumes fast axonal transport. Finally, we demonstrate both in vitro and in vivo that reducing the activity of SARM1, an NAD degradation enzyme, can reduce axonal transport deficits and suppress axon degeneration in NMNAT2 KO neurons. CONCLUSION: NMNAT2 ensures axonal health by maintaining NAD redox potential in distal axons to ensure efficient vesicular glycolysis required for fast axonal transport. American Journal Experts 2023-05-19 /pmc/articles/PMC10246254/ /pubmed/37292715 http://dx.doi.org/10.21203/rs.3.rs-2859584/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. https://creativecommons.org/licenses/by/4.0/License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Article
Yang, Sen
Niou, Zhen-Xian
Enriquez, Andrea
LaMar, Jacob
Huang, Jui-Yen
Ling, Karen
Jafar-Nejad, Paymaan
Gilley, Jonathan
Coleman, Michael P.
Tennessen, Jason M.
Rangaraju, Vidhya
Lu, Hui-Chen
NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title_full NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title_fullStr NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title_full_unstemmed NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title_short NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
title_sort nmnat2 supports vesicular glycolysis via nad homeostasis to fuel fast axonal transport
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246254/
https://www.ncbi.nlm.nih.gov/pubmed/37292715
http://dx.doi.org/10.21203/rs.3.rs-2859584/v1
work_keys_str_mv AT yangsen nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT niouzhenxian nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT enriquezandrea nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT lamarjacob nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT huangjuiyen nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT lingkaren nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT jafarnejadpaymaan nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT gilleyjonathan nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT colemanmichaelp nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT tennessenjasonm nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT rangarajuvidhya nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport
AT luhuichen nmnat2supportsvesicularglycolysisvianadhomeostasistofuelfastaxonaltransport